Gurgaon, India

Simrata Bedi

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2016-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Simrata Bedi: Innovator in Pharmaceutical Composition

Introduction

Simrata Bedi is a notable inventor based in Gurgaon, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of topical compositions for medical treatments. With a total of 2 patents, Bedi's work focuses on innovative solutions for burn treatment and microbial infections.

Latest Patents

One of Simrata Bedi's latest patents is a topical pharmaceutical composition comprising nanonized silver sulfadiazine. This invention relates to a formulation designed for the treatment of burns and microbial infections in both humans and animals. The composition includes 0.1% w/w to 1.0% w/w of silver sulfadiazine, an antimicrobial drug, and 0.2% w/w of chlorhexidine gluconate, an antiseptic. Notably, the silver sulfadiazine is presented in a nanonized form, enhancing its effectiveness.

Career Highlights

Simrata Bedi is currently associated with Sun Pharmaceutical Industries Limited, a leading pharmaceutical company. His work at Sun Pharmaceutical has allowed him to focus on innovative research and development in the pharmaceutical sector. Bedi's contributions have been instrumental in advancing topical treatments that are both effective and safe for patients.

Collaborations

Simrata Bedi has collaborated with several professionals in his field, including Neeta Gupta and Jyoti Srivastava. These collaborations have fostered a productive environment for innovation and have contributed to the success of his projects.

Conclusion

Simrata Bedi's work in pharmaceutical innovations, particularly in topical compositions, showcases his commitment to improving medical treatments. His patents reflect a dedication to addressing critical health issues, making him a valuable contributor to the field of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…